Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma
Clinical trial NCT04189757 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04189757
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-07
- Primary completion
- 2027-06-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.